IBDEI0I5 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,8138,2)
 ;;=^5002742
 ;;^UTILITY(U,$J,358.3,8139,0)
 ;;=E29.1^^55^535^18
 ;;^UTILITY(U,$J,358.3,8139,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8139,1,3,0)
 ;;=3^Testicular hypofunction
 ;;^UTILITY(U,$J,358.3,8139,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,8139,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,8140,0)
 ;;=E53.8^^55^535^6
 ;;^UTILITY(U,$J,358.3,8140,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8140,1,3,0)
 ;;=3^Deficiency of other specified B group vitamins
 ;;^UTILITY(U,$J,358.3,8140,1,4,0)
 ;;=4^E53.8
 ;;^UTILITY(U,$J,358.3,8140,2)
 ;;=^5002797
 ;;^UTILITY(U,$J,358.3,8141,0)
 ;;=E78.0^^55^535^16
 ;;^UTILITY(U,$J,358.3,8141,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8141,1,3,0)
 ;;=3^Pure hypercholesterolemia
 ;;^UTILITY(U,$J,358.3,8141,1,4,0)
 ;;=4^E78.0
 ;;^UTILITY(U,$J,358.3,8141,2)
 ;;=^5002966
 ;;^UTILITY(U,$J,358.3,8142,0)
 ;;=E78.2^^55^535^12
 ;;^UTILITY(U,$J,358.3,8142,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8142,1,3,0)
 ;;=3^Mixed hyperlipidemia
 ;;^UTILITY(U,$J,358.3,8142,1,4,0)
 ;;=4^E78.2
 ;;^UTILITY(U,$J,358.3,8142,2)
 ;;=^78424
 ;;^UTILITY(U,$J,358.3,8143,0)
 ;;=E78.5^^55^535^8
 ;;^UTILITY(U,$J,358.3,8143,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8143,1,3,0)
 ;;=3^Hyperlipidemia, unspecified
 ;;^UTILITY(U,$J,358.3,8143,1,4,0)
 ;;=4^E78.5
 ;;^UTILITY(U,$J,358.3,8143,2)
 ;;=^5002969
 ;;^UTILITY(U,$J,358.3,8144,0)
 ;;=E86.9^^55^535^21
 ;;^UTILITY(U,$J,358.3,8144,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8144,1,3,0)
 ;;=3^Volume depletion, unspecified
 ;;^UTILITY(U,$J,358.3,8144,1,4,0)
 ;;=4^E86.9
 ;;^UTILITY(U,$J,358.3,8144,2)
 ;;=^332840
 ;;^UTILITY(U,$J,358.3,8145,0)
 ;;=E86.0^^55^535^7
 ;;^UTILITY(U,$J,358.3,8145,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8145,1,3,0)
 ;;=3^Dehydration
 ;;^UTILITY(U,$J,358.3,8145,1,4,0)
 ;;=4^E86.0
 ;;^UTILITY(U,$J,358.3,8145,2)
 ;;=^332743
 ;;^UTILITY(U,$J,358.3,8146,0)
 ;;=E87.6^^55^535^10
 ;;^UTILITY(U,$J,358.3,8146,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8146,1,3,0)
 ;;=3^Hypokalemia
 ;;^UTILITY(U,$J,358.3,8146,1,4,0)
 ;;=4^E87.6
 ;;^UTILITY(U,$J,358.3,8146,2)
 ;;=^60610
 ;;^UTILITY(U,$J,358.3,8147,0)
 ;;=E66.3^^55^535^13
 ;;^UTILITY(U,$J,358.3,8147,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8147,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,8147,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,8147,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,8148,0)
 ;;=D64.9^^55^535^5
 ;;^UTILITY(U,$J,358.3,8148,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8148,1,3,0)
 ;;=3^Anemia, unspecified
 ;;^UTILITY(U,$J,358.3,8148,1,4,0)
 ;;=4^D64.9
 ;;^UTILITY(U,$J,358.3,8148,2)
 ;;=^5002351
 ;;^UTILITY(U,$J,358.3,8149,0)
 ;;=M81.0^^55^535^4
 ;;^UTILITY(U,$J,358.3,8149,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8149,1,3,0)
 ;;=3^Age-related osteoporosis w/o current pathological fracture
 ;;^UTILITY(U,$J,358.3,8149,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,8149,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,8150,0)
 ;;=R73.09^^55^535^1
 ;;^UTILITY(U,$J,358.3,8150,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8150,1,3,0)
 ;;=3^Abnormal Glucose NEC
 ;;^UTILITY(U,$J,358.3,8150,1,4,0)
 ;;=4^R73.09
 ;;^UTILITY(U,$J,358.3,8150,2)
 ;;=^5019563
 ;;^UTILITY(U,$J,358.3,8151,0)
 ;;=B96.81^^55^536^58
 ;;^UTILITY(U,$J,358.3,8151,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8151,1,3,0)
 ;;=3^Helicobacter pylori as the cause of diseases classd elswhr
 ;;^UTILITY(U,$J,358.3,8151,1,4,0)
 ;;=4^B96.81
 ;;^UTILITY(U,$J,358.3,8151,2)
 ;;=^5000857
 ;;^UTILITY(U,$J,358.3,8152,0)
 ;;=B15.9^^55^536^62
 ;;^UTILITY(U,$J,358.3,8152,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,8152,1,3,0)
 ;;=3^Hepatitis A without hepatic coma
